Features, pricing, ratings, and pros & cons — compared head-to-head.
Apomatix is a commercial risk assessment tool by Apomatix. DeNexus DeRISK CRQ is a commercial risk assessment tool by DeNexus. Compare features, ratings, integrations, and community reviews side by side to find the best risk assessment fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, integrations, company size fit, here is our conclusion:
Mid-market and SMB risk and compliance teams drowning in spreadsheets will find real value in Apomatix's asset-to-control linkage and automated treatment guidance, which cuts the manual busywork that kills GRC programs. The platform covers NIST CSF 2.0's full risk management chain from GV.RM strategy through ID.RA assessment and ID.AM asset tracking, with built-in ISO 27001 and CIS 20 control testing that actually enforces rigor rather than just logging checkboxes. Skip this if you need deep third-party risk orchestration or if your organization is large enough to justify purpose-built tools for governance, risk, and audit as separate functions; Apomatix consolidates well for lean teams but doesn't scale into enterprise separation-of-duties complexity.
Mid-market and enterprise operations teams managing OT environments need DeNexus DeRISK CRQ because it translates cyber exposure into financial loss metrics that actually move budget conversations with CFOs and board risk committees. The platform quantifies risk across both inside-out asset data and outside-in threat intelligence, then maps attack paths to show exactly which controls would reduce expected loss the most. Skip this if your priority is compliance checkbox coverage; DeRISK CRQ excels at GV.RM risk strategy and ID.RA assessment but assumes you already own asset inventory and basic detection capabilities.
Risk management platform for risk registers, asset & control mgmt.
OT cyber risk quantification platform translating exposures into financial metrics
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing Apomatix vs DeNexus DeRISK CRQ for your risk assessment needs.
Apomatix: Risk management platform for risk registers, asset & control mgmt. built by Apomatix. Core capabilities include Risk identification, analysis, evaluation, and treatment workflows, Risk register with ownership assignment and maturity tracking, Automated risk treatment guidance..
DeNexus DeRISK CRQ: OT cyber risk quantification platform translating exposures into financial metrics. built by DeNexus. Core capabilities include Dynamic risk aggregation using inside-out and outside-in data, Attack-path mapping with actionable attack graphs, Financial quantification of cyber risks with expected loss metrics..
Both serve the Risk Assessment market but differ in approach, feature depth, and target audience.
Apomatix differentiates with Risk identification, analysis, evaluation, and treatment workflows, Risk register with ownership assignment and maturity tracking, Automated risk treatment guidance. DeNexus DeRISK CRQ differentiates with Dynamic risk aggregation using inside-out and outside-in data, Attack-path mapping with actionable attack graphs, Financial quantification of cyber risks with expected loss metrics.
Apomatix is developed by Apomatix. DeNexus DeRISK CRQ is developed by DeNexus. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.
Apomatix and DeNexus DeRISK CRQ serve similar Risk Assessment use cases: both are Risk Assessment tools. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox